FEATURED PRESS

		Planehook Announces Security for General Spaceflight Submitted by David Hook on April 26, 2008 Pioneer in general aviation security blasts off for the stars and co-founds The Space Tourism Security Alliance.

PRESS: Science

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Announces First Patient Completes Hemopurifier® Clinical Study Protocol

Press Release Submitted by Investor Ideas on February 27,2015
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that the first patient enrolled in the Company's FDA approved feasibility study has completed their full Hemopurifier® treatment protocol without any

Medical Technology News: Aethlon Medical (OTCBB: AEMD) Announces Approval of Ebola Treatment Protocol

Press Release Submitted by Investor Ideas on January 03,2015
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that the United States Food and Drug Administration (FDA) has approved a clinical protocol to treat Ebola-infected individuals in the U.S. with the Ae

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients

Press Release Submitted by Investor Ideas on December 03,2014
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, today reported final clinical outcomes, including rapid virologic response (RVR) and sustained virologic response (SVR) rates, in Hepatitis-C virus (HCV) infected indi

Time Magazine Names The Aethlon Hemopurifier® (OTCBB: AEMD) One of the 25 Best Inventions of 2014

Press Release Submitted by Investor Ideas on November 22,2014
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, announced today that the Aethlon Hemopurifier® has been named one of the 25 best inventions of 2014 by Time Magazine. The article can be found on-line at the followin

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Discloses Expanded Access "Emergency Use" Pathway to Treat Ebola in the United States

Press Release Submitted by Investor Ideas on November 20,2014
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed today that it will provide Hemopurifier® therapy under FDA expanded access "emergency use" provisions to support requests from qualified physicians and insti

Medical Technology Breaking News: Aethlon Medical's (OTCBB: AEMD) Hemopurifier® Used in Successful Treatment of Patient with Advanced Ebola Infection

Press Release Submitted by Investor Ideas on November 15,2014
From New York City, NY
The Aethlon Hemopurifier® was used in the successful treatment of a critically-ill Ebola-infected patient in Frankfurt, Germany, according to data presented today at the American Society of Nephrology (ASN) Annual Meeting by Helmut Geiger, M.D., Chief of Nephrology at Goethe University, Frankfurt Un

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Announces Presentation of Ebola Treatment Data This Friday, November 14th at the ASN Annual Meeting

Press Release Submitted by Investor Ideas on November 11,2014
From New York City, NY

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Discloses Ebola Treatment Pathways in the United States

Press Release Submitted by Investor Ideas on October 30,2014
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed today that it will provide Hemopurifier® therapy under FDA compassionate use access provisions to support potential requests by qualified physicians and inst

Biotech News Alert: GenSpera (OTCQB:GNSZ) Announces Completion of Patient Enrollment in the Phase II Clinical Trial of Mipsagargin in Liver Cancer Patients

Press Release Submitted by Investor Ideas on October 10,2014
From New York City, NY

Aethlon Medical (OTCBB: AEMD) and Exosome Sciences Announce Clinical Collaboration with Boston University CTE Center To Advance Diagnostic Candidate to Detect CTE in Former NFL Players

Press Release Submitted by Investor Ideas on September 27,2014
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD) and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), announced today that a clinical collaboration with the Boston University (BU) CTE Center has been established to advance a blood-based diagnostic candidate that could identify Chronic Traumatic Encephalop

Aethlon Medical (OTCBB: AEMD) Announces Dengue Virus Treatment Agreement

Press Release Submitted by Investor Ideas on September 26,2014
From New York City, NY
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has entered into an agreement with Qualtran, LLC that would expand human clinical studies of Hemopurifier® t

Aethlon Medical (OTCQB: AEMD) and Exosome Sciences Announce the Advancement of a Broad-Spectrum Cancer Detection and Monitoring Platform

Press Release Submitted by Investor Ideas on September 09,2014
From New York City, NY
Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) and Exosome Sciences Announce the Advancement of a Broad-Spectrum Cancer Detection and Monitoring Platform

Jean-Michel Cousteau: "The Future of Water – The Challenges and Solutions"

Press Release Submitted by Investor Ideas on August 20,2014
From New York City, NY
Founder of the Ocean Futures Society and Advisory Board member of Ecosphere Technologies, Inc (ESPH) Shares a Legacy of Insight

Biotech News Alert: GenSpera (OTCQB:GNSZ) Announces US Patent for Methods and Compositions for the Detection, Imaging and Treatment of Cancer

Press Release Submitted by Investor Ideas on July 31,2014
From New York City, NY
GenSpera, Inc. (OTCQB:GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The patent US 8,772,226 B2 was issued July 8, 2014

Kama Sutra and the Penis – Pleasure-Enhancing Tips and Tricks

Press Release Submitted by John Dugan on February 06,2013
From Winona, MN
Integrating positions from the Kama Sutra into one’s sexual repertoire can spice up any encounter. These tips can enhance the sensitivity of the penis, making for a more powerful sexual experience.

Current Results 1 - 15 | Next 10

SEARCH PRESS

World	U.S.	Business
Sports	Politics	Law
Technology	Science	Health
Entertainment	Travel	Education
Blogs

POST YOUR PRESS

Post your Press Releases and get more exposure to your business. Thousands of professionals network and market their business online leveraging Social Media. Get Started Today.